Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Arsenic Trioxide and Temozolomide in Combination With Radiation Therapy for Patients With Malignant Gliomas

NCT00275067 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00275067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00275067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Arsenic Trioxide and Temozolomide in Combination With Radiation Therapy for Patients With Malignant Gliomas
Lead sponsor
Northwestern University
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2005
Completion date
May 31, 2021
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors